Hypercalcemia

4

Review clinical trials related to Hypercalcemia. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Hypercalcemia After Paraffin Oil Injection

Today, there is an increased use of non-medical, invasive cosmetic treatments globally without sufficient awareness of possible health risks. A particular problem is young men injecting large amounts of paraffin oil into skeletal muscles especially on upper arms and chest to increase the visible size of the muscles. Several case reports have suggested that intramuscular injection of paraffin oil induces foreign body reaction and granuloma formation and subsequently hypercalcemia. Our hypothesis is that increased generation of activated vitamin D (1,25(OH)2D3) in the marcrophages may be responsible for the persistent hypercalcemia. Now trhe investigators want to include a large group of men who injected 100-10.000 ml paraffin oil to identify risk factors for developing hypercalcemia and try to understand the pathogenesis of the disease. Additionally, granuloma tissue from selected patients will be cultured ex vivo to investigate whether they produce 1,25(OH)2D3 or PTHrP and to test which drugs can most effectively be used to lower calcium levels in these men. Subsequently, we will try to stratify the men according to the severity of the changes in calcium homeostasis as we suggest that this stratification will be the basis for future intervention trials

Participants needed: 200
Trial details
Age: 18-80Biological sex: MaleType: ObservationalSponsor: Martin Blomberg JensenUpdated: Apr 6, 2025Locations: 1
Eligibility criteria

previous injection of paraffin oil into the body

inability to walk [+2]

Status: Recruiting

Exploring Pathogenesis and Treatment of Hypercalcemia Caused by Intramuscular Injection of Paraffinoil

The aim of the study is to characterize paraffin oil induced granulomatous disease. We will investigate pathogenesis and natural history of paraffin disease. Subsequently, through further translational studies, we intend to identify novel treatments to be tested in future randomized clinical trials.

Participants needed: 200
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: Herlev HospitalUpdated: Oct 1, 2024Locations: 1
Eligibility criteria

previous intramuscular injection of paraffin or other oil

none

Status: Recruiting

Calcitonin Pre-treatment to Improve SPECT-CT Sensitivity

Patients with biochemically confirmed primary hyperparathyroidism and non-localizing SPECT-CT exam within the past year will be included. Subjects will be treated with calcitonin to lower calcium levels immediately prior to reimaging. The goal of this study is to determine whether lowering calcium will improve uptake/retention of sestamibi and improve sensitivity of SPECT-CT to localize parathyroid adenoma.

Participants needed: 37
Trial details
Phase: Phase 4Age: 18+Biological sex: AllType: InterventionalSponsor: Joseph SferraUpdated: Sep 19, 2024Locations: 1
Eligibility criteria

Diagnosis of primary hyperparathyroidism [+6]

Previous surgery to the neck, including resection of parathyroid tissue, except... [+13]

Status: Recruiting

Registry for Hypoparathyroidism Wuerzburg

Long-term conventional treatment of chronic hypoparathyroidism does not fully restore calcium homeostasis leading to increased morbidity, emergency events and reduced subjective health status. To further investigate general morbidity, hypocalcemic events, subjective and daily life performance in patients with chronic hypoparathyroidism a standardized interview as well as blood sampling and examinations such as echocardiography and renal ultrasound are performed.

Participants needed: 300
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: University of WuerzburgUpdated: Nov 8, 2022Locations: 1
Eligibility criteria

age of 18 [+2]

age <18 years [+1]